News & Events
Signify Research’s latest external press coverage, company news and updates on key industry events that our analysts are attending
Workflow Applications Drive Radiology Analytics Market
January 31st 2020 – Written by Steve Holloway – Featured on AuntMinnie.com – The utilization of artificial intelligence (AI) to assist with image interpretation may generate much of the headlines in radiology analytics, buts its workflow-enhancing tools — some based on AI and some not — that currently offer the most proven value for today’s […]
What Can the Cloud Offer for Enterprise Imaging?
January 31st 2020, Written by Steve Holloway – Featured on AuntMinnie.com – Healthcare organizations are increasingly pursuing an enterprise imagine strategy, driven by factors such as growing volumes of clinical and imaging data and the desire to integrate everything on a single platform. For some, cloud technology has become a key element in the decision-making […]
Study identifies drug design applications as main recipient of AI investment
08th January 2020 – Written by Ulrik Kristensen, Ph.D – Featured in Drug Target Review – Research suggests that over half of the total $5.2bn investment for artificial intelligence in pharma went to drug design applications in 2019, but overall investment is slowing. Research suggests that over half of the total $5.2bn investment for artificial intelligence […]
VC Funding for AI in Drug Development & Clinical Trials Hits $ 5.2B
06th January 2020 – Written by Ulrik Kristensen, Ph.D – Featured on Finanzen.net – The market for AI in drug development and clinical trials is maturing and entering a new phase; total funding in the industry has reached $ 5.2B , but investments have slowed down in 2019 and only 4 new companies were formed. Any new start-ups will have […]
VC Funding for Artificial Intelligence in Drug Development Climbs to $5.2 Billion
06th January 2020 – Written by Ulrik Kristensen, Ph.D – Features on BioSpace.com – The last few years there has been regular news about advances in artificial intelligence (AI) and machine learning increasingly being a focus of interest for the biopharma industry. For example, in September 2019, San Francisco-based Atomwise, which focuses on AI for […]